LV10712B - 2-ciano-3-hydroxypropene amides - Google Patents

2-ciano-3-hydroxypropene amides Download PDF

Info

Publication number
LV10712B
LV10712B LVP-94-02A LV940002A LV10712B LV 10712 B LV10712 B LV 10712B LV 940002 A LV940002 A LV 940002A LV 10712 B LV10712 B LV 10712B
Authority
LV
Latvia
Prior art keywords
group
formula
compound
cyclopropyl
cyano
Prior art date
Application number
LVP-94-02A
Other languages
English (en)
Latvian (lv)
Other versions
LV10712A (lv
Inventor
Kuo Elizabeth Anne
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of LV10712A publication Critical patent/LV10712A/xx
Publication of LV10712B publication Critical patent/LV10712B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
LVP-94-02A 1993-01-05 1994-01-04 2-ciano-3-hydroxypropene amides LV10712B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939300083A GB9300083D0 (en) 1993-01-05 1993-01-05 Chemical compounds

Publications (2)

Publication Number Publication Date
LV10712A LV10712A (lv) 1995-06-20
LV10712B true LV10712B (en) 1995-12-20

Family

ID=10728304

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-94-02A LV10712B (en) 1993-01-05 1994-01-04 2-ciano-3-hydroxypropene amides

Country Status (33)

Country Link
US (1) US5346912A (sl)
EP (1) EP0606175B1 (sl)
JP (1) JP3334988B2 (sl)
KR (1) KR100295717B1 (sl)
CN (1) CN1042935C (sl)
AT (1) ATE128968T1 (sl)
AU (1) AU663017B2 (sl)
BR (1) BR9400017A (sl)
CA (1) CA2112866C (sl)
CZ (1) CZ283948B6 (sl)
DE (1) DE69400024T2 (sl)
DK (1) DK0606175T3 (sl)
EE (1) EE03001B1 (sl)
ES (1) ES2078130T3 (sl)
FI (1) FI106553B (sl)
GB (1) GB9300083D0 (sl)
GR (1) GR3017723T3 (sl)
HR (1) HRP940006B1 (sl)
HU (1) HU216835B (sl)
IL (1) IL107788A (sl)
LT (1) LT3766B (sl)
LV (1) LV10712B (sl)
MX (1) MX9400274A (sl)
NO (1) NO300839B1 (sl)
NZ (1) NZ250520A (sl)
PL (1) PL175135B1 (sl)
RU (1) RU2126387C1 (sl)
SI (1) SI9300686A (sl)
SK (1) SK280508B6 (sl)
TW (1) TW259785B (sl)
UA (1) UA40573C2 (sl)
YU (1) YU49047B (sl)
ZA (1) ZA939118B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006153A1 (en) * 1998-07-28 2000-02-10 Smithkline Beecham Corporation Propenamides as ccr5 modulators
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US8642597B2 (en) 2007-08-27 2014-02-04 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2010034737A1 (en) 2008-09-24 2010-04-01 Basf Se Pyrazole compounds for controlling invertebrate pests
ES2461618T3 (es) 2009-07-06 2014-05-20 Basf Se Compuestos de piridacina para el control de plagas de invertebrados
ES2472918T3 (es) 2009-07-06 2014-07-03 Basf Se Compuestos de piridazina para controlar plagas de invertebrados
CN102469785A (zh) 2009-07-24 2012-05-23 巴斯夫欧洲公司 防治无脊椎动物害虫的吡啶衍生物
MX2016006678A (es) 2013-11-22 2016-09-13 Genzyme Corp Nuevos metodos para tratar enfermedades neurodegenerativas.
CN105693574B (zh) * 2014-11-25 2017-12-19 中国科学院大连化学物理研究所 2‑烷硫基烯酰胺衍生物及其合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4435407A (en) * 1982-01-07 1984-03-06 Ciba-Geigy Corporation Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
DE3534440A1 (de) 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US4888357A (en) 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
IL92508A0 (en) * 1988-12-08 1990-08-31 Ciba Geigy Ag Novel alpha-cyano-beta-oxopropionamides
EP0527736B1 (de) * 1990-05-18 1997-04-16 Hoechst Aktiengesellschaft Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf History of 3-cycloalkyl-prop-2-anamide

Also Published As

Publication number Publication date
UA40573C2 (uk) 2001-08-15
CA2112866C (fr) 2007-03-13
FI940031A (fi) 1994-07-06
EP0606175B1 (fr) 1995-10-11
IL107788A (en) 1998-08-16
SK149593A3 (en) 1994-12-07
BR9400017A (pt) 1994-08-02
DE69400024T2 (de) 1996-04-04
ZA939118B (en) 1995-01-18
LTIP1634A (en) 1995-02-27
US5346912A (en) 1994-09-13
NZ250520A (en) 1996-08-27
FI106553B (fi) 2001-02-28
FI940031A0 (fi) 1994-01-04
DK0606175T3 (da) 1996-02-19
CN1042935C (zh) 1999-04-14
HRP940006A2 (en) 1996-10-31
HRP940006B1 (en) 1999-12-31
EE03001B1 (et) 1997-06-16
ES2078130T3 (es) 1995-12-01
HU216835B (hu) 1999-09-28
JP3334988B2 (ja) 2002-10-15
ATE128968T1 (de) 1995-10-15
YU82593A (sh) 1996-07-24
NO940020L (sl) 1994-07-06
RU2126387C1 (ru) 1999-02-20
SI9300686A (en) 1994-09-30
KR940018363A (ko) 1994-08-16
CZ292193A3 (en) 1994-07-13
MX9400274A (es) 1994-08-31
NO940020D0 (no) 1994-01-04
CZ283948B6 (cs) 1998-07-15
HU9400033D0 (en) 1994-05-30
JPH06211793A (ja) 1994-08-02
CA2112866A1 (fr) 1994-07-06
AU663017B2 (en) 1995-09-21
DE69400024D1 (de) 1995-11-16
EP0606175A1 (fr) 1994-07-13
YU49047B (sh) 2003-07-07
CN1097005A (zh) 1995-01-04
SK280508B6 (sk) 2000-03-13
LT3766B (en) 1996-03-25
RU94000064A (ru) 1996-07-10
GR3017723T3 (en) 1996-01-31
AU5213093A (en) 1994-07-14
GB9300083D0 (en) 1993-03-03
LV10712A (lv) 1995-06-20
KR100295717B1 (ko) 2001-11-05
HUT71471A (en) 1995-11-28
PL301774A1 (en) 1994-07-11
IL107788A0 (en) 1994-02-27
TW259785B (en) 1995-10-11
NO300839B1 (no) 1997-08-04
PL175135B1 (pl) 1998-11-30

Similar Documents

Publication Publication Date Title
DE69410092T2 (de) Phenyl heterocyclen als cyclooxygenase-2 inhibitoren
DE69826695T2 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
AU652088B2 (en) Chemical compounds
DE69810652T2 (de) Verfahren um diaryl-pyridine zu herstellen, die als cox-inhibitoren verwendbar sind
JP2015522547A (ja) カテコールo−メチルトランスフェラーゼ活性阻害化合物
JP2594855B2 (ja) 新規な3−シクロアルキルプロパンアミド、それらの互変異性形及び塩類、それらの製造法、薬剤としての使用並びにそれらを含有する組成物
LV10712B (en) 2-ciano-3-hydroxypropene amides
JP2024524765A (ja) アミド化合物とその応用
JP3642797B2 (ja) フェニルカルボキサミドイソオキサゾールの新誘導体及びそれらの塩類、それらの製造法及びこの製造法の新規な中間体、それらの薬剤としての用途並びにそれらを含有する製薬組成物
FI79308C (fi) Foerfarande foer framstaellning av som antiinflammatoriska medel anvaendbara 2,3-diaryl-5-halogentiofener.
JP3705614B2 (ja) 化合物
FR2492378A1 (fr) Derives de type 6h-dibenzo(b,d) pyranne 6-substitues utiles notamment comme medicaments antiulcereux, immunomodulateurs et antiviraux et procedes de leur preparation
HU210164B (en) Process for preparing 3-cycloalkyl-prop-2-enamide derivatives and pharmaceutical compn. contg. them
WO1994018165A1 (en) Sulfonamide compounds as opioid k-receptor agonists
JPS6168488A (ja) 新規なピリジルエチル‐ジヒドロピリジン類
RU2073667C1 (ru) 3-циклоалкил-пропанамиды, проявляющие противовоспалительную и иммуноподавляющую активность, способ их получения, цианамид и фармацевтическая композиция
JP2005126340A (ja) 置換ピリドン類の製造法、その原料化合物及びその製造方法
JPS60132988A (ja) ヒドロキシ‐テトラヒドロピリジンラクトン類
JP2535533B2 (ja) ベンゾジオキソ−ル誘導体
JPH01275591A (ja) ジヒドロピリジン−5−ホスホン酸誘導体
JPH0655751B2 (ja) ジヒドロピリジンホスホン酸環状エステル
JPH01249759A (ja) イソオキサゾリン−3−オン誘導体およびその用途
JPH03109363A (ja) シクロヘキサジエノン誘導体